Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by Wino115on Feb 02, 2022 9:59pm
201 Views
Post# 34391701

RE:RE:RE:RE:Biden prioritizing ending cancer in speech

RE:RE:RE:RE:Biden prioritizing ending cancer in speechFunny you mention this as there's also an article today about a guy who started receiving gene therapy for his leukemia and is "cured" in the actual word.  So they're getting there.

https://www.modernhealthcare.com/technology/cancer-patients-cure-gene-therapy




jfm1330 wrote: Many cancers can already be cured, as time will go on, more and more will be curable, and more and more will become similar to chronic diseases. Many cancers are already treated over the long term as a chronic disease, like many prostate cancers wher patients can survive 15-25 years post diagnostic, without ever curing it, but by being able to stop progression with regular treatments. That being said, it is clear that there is a lot to do for the more aggressive cancers. Also, I think it will be hard to cure more advanced cancers with a single therapy, as these advanced cancers are genetically heterogenous and involves cancerous stem cells.


<< Previous
Bullboard Posts
Next >>